Zacks.com on MSN2d
Alnylam Gets FDA Nod for Expanded Use of Amvuttra in CardiomyopathyALNY secures FDA approval for an sNDA in the United States, seeking the label expansion of Amvuttra to treat ATTR amyloidosis with cardiomyopathy.
The U.S. plastics industry can overcome its current downturn by redefining its value proposition and aligning with market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback